Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.

Cortellini A, Bersanelli M, Santini D, Buti S, Tiseo M, Cannita K, Perrone F, Giusti R, De Tursi M, Zoratto F, Marconcini R, Russano M, Zeppola T, Anesi C, Filetti M, Marchetti P, Botticelli A, Gelibter A, De Galitiis F, Vitale MG, Rastelli F, Tudini M, Silva RR, Atzori F, Chiari R, Ricciuti B, De Giglio A, Migliorino MR, Mallardo D, Vanella V, Mosillo C, Bracarda S, Rinaldi S, Berardi R, Natoli C, Ficorella C, Porzio G, Ascierto PA.

Eur J Cancer. 2020 Feb 4;128:17-26. doi: 10.1016/j.ejca.2019.12.031. [Epub ahead of print]

PMID:
32109847
2.

A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy.

Parisi A, Cortellini A, Roberto M, Venditti O, Santini D, Dell'Aquila E, Stellato M, Marchetti P, Occhipinti M, Zoratto F, Mazzuca F, Tinari N, De Tursi M, Iezzi L, Natoli C, Ratti M, Pizzo C, Ghidini M, Ficorella C, Cannita K.

Ann Oncol. 2019 Jul;30 Suppl 4:iv27. doi: 10.1093/annonc/mdz155.100. Epub 2019 Dec 4. No abstract available.

3.

Striatal dynamics as determinants of reduced gambling vulnerability in the NHE rat model of ADHD.

Oggiano M, Zoratto F, Palombelli G, Festucci F, Laviola G, Curcio G, Canese R, Adriani W.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109886. doi: 10.1016/j.pnpbp.2020.109886. Epub 2020 Feb 8.

PMID:
32045636
4.

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.

Cortellini A, Buti S, Bersanelli M, Giusti R, Perrone F, Di Marino P, Tinari N, De Tursi M, Grassadonia A, Cannita K, Tessitore A, Zoratto F, Veltri E, Malorgio F, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Cappellini GCA, De Galitiis F, Vitale MG, Rastelli F, Pergolesi F, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Iacono D, Migliorino MR, Gelibter A, Occhipinti MA, Martella F, Inno A, Gori S, Bracarda S, Zannori C, Mosillo C, Parisi A, Porzio G, Mallardo D, Fargnoli MC, Tiseo M, Santini D, Ascierto PA, Ficorella C.

Oncoimmunology. 2020 Jan 7;9(1):1710389. doi: 10.1080/2162402X.2019.1710389. eCollection 2020.

5.

Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.

Ridolfi L, De Rosa F, Petracci E, Tanda ET, Marra E, Pigozzo J, Marconcini R, Guida M, Cappellini GCA, Gallizzi G, Occelli M, Pala L, Gambale E, Bersanelli M, Galdo G, Cortellini A, Morgese F, Zoratto F, Stucci LS, Strippoli S, Guidoboni M; Italian Melanoma Intergroup (IMI).

J Geriatr Oncol. 2020 Jan 9. pii: S1879-4068(19)30356-X. doi: 10.1016/j.jgo.2019.12.012. [Epub ahead of print]

PMID:
31928943
6.

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study.

Grassadonia A, Di Marino P, Ficorella C, Cortellini A, Cannita K, Parisi A, Gamucci T, Zoratto F, Vici P, Barba M, Porreca E, Neri M, Veronese A, Natoli C, De Tursi M, Tinari N.

J Cancer. 2019 Oct 15;10(24):5926-5934. doi: 10.7150/jca.34550. eCollection 2019.

7.

Anhedonia across borders: Transdiagnostic relevance of reward dysfunction for noninvasive brain stimulation endophenotypes.

Spano MC, Lorusso M, Pettorruso M, Zoratto F, Di Giuda D, Martinotti G, di Giannantonio M.

CNS Neurosci Ther. 2019 Nov;25(11):1229-1236. doi: 10.1111/cns.13230. Epub 2019 Oct 22. Review.

8.

Anatomical and behavioral impact of a lentiviral tool tapping onto hippocampal serotonin reuptake in rats.

Zoratto F, Buccheri C, Mura R, Altabella L, Vanneste M, Villotte M, Laviola G, Dauphin F, Paizanis E, Adriani W, Canese R.

Synapse. 2020 Apr;74(4):e22138. doi: 10.1002/syn.22138. Epub 2019 Nov 11.

PMID:
31587367
9.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Cortellini A, Leonetti A, Catino A, Pizzutillo P, Ricciuti B, De Giglio A, Chiari R, Bordi P, Santini D, Giusti R, De Tursi M, Brocco D, Zoratto F, Rastelli F, Citarella F, Russano M, Filetti M, Marchetti P, Berardi R, Torniai M, Cortinovis D, Sala E, Maggioni C, Follador A, Macerelli M, Nigro O, Tuzi A, Iacono D, Migliorino MR, Banna G, Porzio G, Cannita K, Ferrara MG, Bria E, Galetta D, Ficorella C, Tiseo M.

Clin Transl Oncol. 2019 Aug 7. doi: 10.1007/s12094-019-02193-w. [Epub ahead of print]

PMID:
31392645
10.

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.

Parisi A, Cortellini A, Roberto M, Venditti O, Santini D, Dell'Aquila E, Stellato M, Marchetti P, Occhipinti MA, Zoratto F, Mazzuca F, Tinari N, De Tursi M, Iezzi L, Natoli C, Ratti M, Pizzo C, Ghidini M, Porzio G, Ficorella C, Cannita K.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2365-2373. doi: 10.1007/s00432-019-02971-7. Epub 2019 Jul 6.

PMID:
31280347
11.

Reduced adolescent risk-assessment and lower nicotinic beta-2 expression in rats exposed to nicotine through lactation by forcedly drinking dams.

Faure A, Zoratto F, Chirico D, Romano E, Mancinelli R, Saso L, Callebert J, Laviola G, Granon S, Adriani W.

Neuroscience. 2019 Aug 10;413:64-76. doi: 10.1016/j.neuroscience.2019.06.014. Epub 2019 Jun 19.

PMID:
31228592
12.

Methylphenidate administration promotes sociability and reduces aggression in a mouse model of callousness.

Zoratto F, Franchi F, Macrì S, Laviola G.

Psychopharmacology (Berl). 2019 Sep;236(9):2593-2611. doi: 10.1007/s00213-019-05229-9. Epub 2019 Apr 6.

PMID:
30955107
13.

Complex patterns of collective escape in starling flocks under predation.

Storms RF, Carere C, Zoratto F, Hemelrijk CK.

Behav Ecol Sociobiol. 2019;73(1):10. doi: 10.1007/s00265-018-2609-0. Epub 2019 Jan 19.

14.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

Cortellini A, Chiari R, Ricciuti B, Metro G, Perrone F, Tiseo M, Bersanelli M, Bordi P, Santini D, Giusti R, Grassadonia A, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Iacono D, Migliorino MR, Porzio G, Cannita K, Ficorella C, Buti S.

Clin Lung Cancer. 2019 Jul;20(4):237-247.e1. doi: 10.1016/j.cllc.2019.02.006. Epub 2019 Feb 21.

PMID:
30885550
15.

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.

Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F, Giusti R, Tiseo M, Michiara M, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Rastelli F, Pergolesi F, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, De Giglio A, Iacono D, Gelibter A, Occhipinti MA, Parisi A, Porzio G, Fargnoli MC, Ascierto PA, Ficorella C, Natoli C.

J Immunother Cancer. 2019 Feb 27;7(1):57. doi: 10.1186/s40425-019-0527-y.

16.

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.

Cortellini A, Buti S, Santini D, Perrone F, Giusti R, Tiseo M, Bersanelli M, Michiara M, Grassadonia A, Brocco D, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Sabbatini R, Bracarda S, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, Iacono D, Migliorino MR, Rossi A, Porzio G, Cannita K, Ciciarelli V, Fargnoli MC, Ascierto PA, Ficorella C.

Oncologist. 2019 Jun;24(6):e327-e337. doi: 10.1634/theoncologist.2018-0618. Epub 2019 Feb 22.

17.

Inside the Developing Brain to Understand Teen Behavior From Rat Models: Metabolic, Structural, and Functional-Connectivity Alterations Among Limbic Structures Across Three Pre-adolescent Stages.

Zoratto F, Altabella L, Tistarelli N, Laviola G, Adriani W, Canese R.

Front Behav Neurosci. 2018 Sep 24;12:208. doi: 10.3389/fnbeh.2018.00208. eCollection 2018.

18.

Proof of nicotine transfer to rat pups through maternal breast feeding to evaluate the neurobehavioral consequences of nicotine exposure.

Famele M, Mancinelli R, Ferranti C, Zoratto F, Thomas F, Romano E, Laviola G, Adriani W, Draisci R.

Ann Ist Super Sanita. 2018 Jul-Sep;54(3):176-184. doi: 10.4415/ANN_18_03_03.

19.

Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness.

Zoratto F, Sbriccoli M, Martinelli A, Glennon JC, Macrì S, Laviola G.

Neuropharmacology. 2018 Dec;143:250-267. doi: 10.1016/j.neuropharm.2018.09.010. Epub 2018 Sep 10.

PMID:
30213592
20.

Variability in the "stereotyped" prey capture sequence of male cuttlefish (Sepia officinalis) could relate to personality differences.

Zoratto F, Cordeschi G, Grignani G, Bonanni R, Alleva E, Nascetti G, Mather JA, Carere C.

Anim Cogn. 2018 Nov;21(6):773-785. doi: 10.1007/s10071-018-1209-8. Epub 2018 Sep 3.

PMID:
30178104
21.

Scrambler therapy in the management of somatosensory signs and symptoms related to neuropathic pain: an exploratory and prospective analysis.

Russo D, Zoratto F, Tirocchi G, Guarda M.

Acta Biomed. 2018 Jun 7;89(2):180-185. doi: 10.23750/abm.v89i2.5704.

22.

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.

Cortellini A, Bersanelli M, Buti S, Gambale E, Atzori F, Zoratto F, Parisi A, Brocco D, Pireddu A, Cannita K, Iacono D, Migliorino MR, Gamucci T, De Tursi M, Sidoni T, Tiseo M, Michiara M, Papa A, Angius G, Tomao S, Fargnoli MC, Natoli C, Ficorella C.

Immunotherapy. 2018 Jun;10(8):643-655. doi: 10.2217/imt-2017-0167. Epub 2018 Mar 22.

23.

Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia.

Cinque S, Zoratto F, Poleggi A, Leo D, Cerniglia L, Cimino S, Tambelli R, Alleva E, Gainetdinov RR, Laviola G, Adriani W.

Front Psychiatry. 2018 Feb 22;9:43. doi: 10.3389/fpsyt.2018.00043. eCollection 2018.

24.

Social modulation of risky decision-making in rats (Rattus norvegicus) and tufted capuchin monkeys (Sapajus spp.).

Zoratto F, Oddi G, Gori E, Micucci A, De Petrillo F, Paglieri F, Adriani W, Laviola G, Addessi E.

Behav Brain Res. 2018 Jul 16;347:37-48. doi: 10.1016/j.bbr.2018.02.033. Epub 2018 Feb 24.

PMID:
29486266
25.

Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.

Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EV, Niello M, Espinoza S, Sotnikova TD, Hoener MC, Laviola G, Fumagalli F, Adriani W, Gainetdinov RR.

J Neurosci. 2018 Feb 21;38(8):1959-1972. doi: 10.1523/JNEUROSCI.1931-17.2018. Epub 2018 Jan 18.

26.

Low empathy-like behaviour in male mice associates with impaired sociability, emotional memory, physiological stress reactivity and variations in neurobiological regulations.

Laviola G, Zoratto F, Ingiosi D, Carito V, Huzard D, Fiore M, Macrì S.

PLoS One. 2017 Dec 4;12(12):e0188907. doi: 10.1371/journal.pone.0188907. eCollection 2017.

27.

LP-211, a selective 5-HT7 receptor agonist, increases novelty-preference and promotes risk-prone behavior in rats.

Beaudet G, Paizanis E, Zoratto F, Lacivita E, Leopoldo M, Freret T, Laviola G, Boulouard M, Adriani W.

Synapse. 2017 Dec;71(12). doi: 10.1002/syn.21995. Epub 2017 Aug 17.

PMID:
28752923
28.

Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model.

Zoratto F, Palombelli GM, Ruocco LA, Carboni E, Laviola G, Sadile AG, Adriani W, Canese R.

Behav Brain Res. 2017 Aug 30;333:171-178. doi: 10.1016/j.bbr.2017.06.026. Epub 2017 Jun 26.

PMID:
28655564
29.

The current clinical knowledge on the treatment of gambling disorder: A summary.

Hloch K, Mladěnka P, Doseděl M, Adriani W, Zoratto F.

Synapse. 2017 Aug;71(8). doi: 10.1002/syn.21976. Epub 2017 Apr 21. Review.

PMID:
28420033
30.

Can laboratory animals violate behavioural norms? Towards a preclinical model of conduct disorder.

Macrì S, Zoratto F, Chiarotti F, Laviola G.

Neurosci Biobehav Rev. 2018 Aug;91:102-111. doi: 10.1016/j.neubiorev.2017.01.047. Epub 2017 Feb 3. Review.

PMID:
28167096
31.

Internet Addiction in adolescence: Neurobiological, psychosocial and clinical issues.

Cerniglia L, Zoratto F, Cimino S, Laviola G, Ammaniti M, Adriani W.

Neurosci Biobehav Rev. 2017 May;76(Pt A):174-184. doi: 10.1016/j.neubiorev.2016.12.024. Epub 2016 Dec 24. Review.

PMID:
28027952
32.

Down-regulation of serotonin and dopamine transporter genes in individual rats expressing a gambling-prone profile: A possible role for epigenetic mechanisms.

Zoratto F, Romano E, Pascale E, Pucci M, Falconi A, Dell'Osso B, Maccarrone M, Laviola G, D'Addario C, Adriani W.

Neuroscience. 2017 Jan 6;340:101-116. doi: 10.1016/j.neuroscience.2016.10.041. Epub 2016 Oct 24.

PMID:
27789384
33.

Polymorphism of the 3'-UTR of the dopamine transporter gene (DAT) in New World monkeys.

Lucarelli M, Visalberghi E, Adriani W, Addessi E, Pierandrei S, Manciocco A, Zoratto F, Tamellini A, Vitale A, Laviola G, Alfaro JL, Pascale E.

Primates. 2017 Jan;58(1):169-178. doi: 10.1007/s10329-016-0560-0. Epub 2016 Aug 8.

PMID:
27503104
34.

Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.

Graziano F, Ruzzo A, Giacomini E, Ricciardi T, Aprile G, Loupakis F, Lorenzini P, Ongaro E, Zoratto F, Catalano V, Sarti D, Rulli E, Cremolini C, De Nictolis M, De Maglio G, Falcone A, Fiorentini G, Magnani M.

Pharmacogenomics J. 2017 Jun;17(3):258-264. doi: 10.1038/tpj.2016.13. Epub 2016 Mar 1.

PMID:
26927284
35.

The subjective value of probabilistic outcomes: Impact of reward magnitude on choice with uncertain rewards in rats.

Zoratto F, Laviola G, Adriani W.

Neurosci Lett. 2016 Mar 23;617:225-31. doi: 10.1016/j.neulet.2016.02.026. Epub 2016 Feb 22.

PMID:
26905669
36.

Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation.

Papa A, Rossi L, Verrico M, Di Cristofano C, Moretti V, Strudel M, Zoratto F, Minozzi M, Tomao S.

Clin Respir J. 2017 Sep;11(5):574-578. doi: 10.1111/crj.12385. Epub 2015 Oct 20.

PMID:
26365150
37.

Stimulation of 5-HT7 receptor during adolescence determines its persistent upregulation in adult rat forebrain areas.

Nativio P, Zoratto F, Romano E, Lacivita E, Leopoldo M, Pascale E, Passarelli F, Laviola G, Adriani W.

Synapse. 2015 Nov;69(11):533-42. doi: 10.1002/syn.21846. Epub 2015 Sep 14.

PMID:
26364910
38.

Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.

Giordani E, Zoratto F, Strudel M, Papa A, Rossi L, Minozzi M, Caruso D, Zaccarelli E, Verrico M, Tomao S.

Curr Cancer Drug Targets. 2016;16(2):175-85. Review.

PMID:
26278713
39.

Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study.

Altabella L, Sbriccoli M, Zoratto F, Poleggi A, Vinci R, Lacivita E, Leopoldo M, Laviola G, Cardone F, Canese R, Adriani W.

Front Behav Neurosci. 2014 Dec 16;8:427. doi: 10.3389/fnbeh.2014.00427. eCollection 2014.

40.

Angiogenesis and antiangiogenic agents in cervical cancer.

Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S.

Onco Targets Ther. 2014 Dec 3;7:2237-48. doi: 10.2147/OTT.S68286. eCollection 2014. Review.

41.

From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors.

Zoratto F, Rossi L, Giordani E, Strudel M, Papa A, Tomao S.

Tumour Biol. 2014 Sep;35(9):8471-82. doi: 10.1007/s13277-014-2367-1. Epub 2014 Jul 26. Review.

PMID:
25062724
42.

Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S.

Tumour Biol. 2014 Jul;35(7):6195-206. doi: 10.1007/s13277-014-1845-9. Epub 2014 Mar 28. Review.

PMID:
25051912
43.

Individual differences in gambling proneness among rats and common marmosets: an automated choice task.

Zoratto F, Sinclair E, Manciocco A, Vitale A, Laviola G, Adriani W.

Biomed Res Int. 2014;2014:927685. doi: 10.1155/2014/927685. Epub 2014 May 27.

44.

Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist.

Canese R, Zoratto F, Altabella L, Porcari P, Mercurio L, de Pasquale F, Butti E, Martino G, Lacivita E, Leopoldo M, Laviola G, Adriani W.

Psychopharmacology (Berl). 2015 Jan;232(1):75-89. doi: 10.1007/s00213-014-3639-6. Epub 2014 Jun 13.

PMID:
24923983
45.

Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.

Schirripa M, Cremolini C, Loupakis F, Morvillo M, Bergamo F, Zoratto F, Salvatore L, Antoniotti C, Marmorino F, Sensi E, Lupi C, Fontanini G, De Gregorio V, Giannini R, Basolo F, Masi G, Falcone A.

Int J Cancer. 2015 Jan 1;136(1):83-90. doi: 10.1002/ijc.28955. Epub 2014 May 28.

46.

Nonhuman gamblers: lessons from rodents, primates, and robots.

Paglieri F, Addessi E, De Petrillo F, Laviola G, Mirolli M, Parisi D, Petrosino G, Ventricelli M, Zoratto F, Adriani W.

Front Behav Neurosci. 2014 Feb 11;8:33. doi: 10.3389/fnbeh.2014.00033. eCollection 2014. Review.

47.

MR imaging-detectable metabolic alterations in attention deficit/hyperactivity disorder: from preclinical to clinical studies.

Altabella L, Zoratto F, Adriani W, Canese R.

AJNR Am J Neuroradiol. 2014 Jun;35(6 Suppl):S55-63. doi: 10.3174/ajnr.A3843. Epub 2014 Jan 30. Review.

48.

Behavioural response of European starlings exposed to video playback of conspecific flocks: effect of social context and predator threat.

Zoratto F, Manzari L, Oddi L, Pinxten R, Eens M, Santucci D, Alleva E, Carere C.

Behav Processes. 2014 Mar;103:269-77. doi: 10.1016/j.beproc.2014.01.012. Epub 2014 Jan 24.

PMID:
24468212
49.

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S.

Cancer Manag Res. 2013 Nov 19;5:377-85. doi: 10.2147/CMAR.S47986. Review.

50.

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation.

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S.

Onco Targets Ther. 2013 Nov 29;6:1761-9. doi: 10.2147/OTT.S43828. eCollection 2013.

Supplemental Content

Loading ...
Support Center